Commission Failed in Duty Under Article 85 (1) of the Treaty, According to Court Decision

Pharma Behemoth Hit with Big Bucks Over Mind-Fuzzy Tumors: Bayer's Brainwreck

• ⏱️ ~ 1 Min

Medication-induced pituitary tumor results in compensation claim against Bayer - Commission Failed in Duty Under Article 85 (1) of the Treaty, According to Court Decision

In a stunner of a trial, a French court claimed that German pharma elephant Bayer, and three fellow 'pill pals', should cough up €300,000 to a patient who took a hormone pill and wound up with mind-bending tumors. The ruling came down Monday in Poitiers, where the court declared these suspects all "accountable for the damage inflicted."

The victim took Androcur—a hormone cocktail lantern-named cyproterone acetate—for over two decades. Since 2013, that fateful decision led to a flurry of benign brain tumors causing vision loss, foggy memories, and debilitating fatigue.

Court: Bayer's Bogus Brainstorming

The aggrieved party argued these squirming symptoms were detailed in a 2008 scientific tidbit. The court admitted the meds played a part in triggering the aforementioned tumors.

The pharma muckety-mucks were pinpointed for neglecting to spill the beans to their vulnerable customer. The attorney for the victim called the verdict a landmark case, hinting at a wave of similar claims to come.

• Bayer
• Pharmaceutical Regime

Background:

Androcur's primary purpose is to help manage conditions like hirsutism and hormone therapy for transgender women. However, it has been linked to a rise in meningioma tumors, particularly when large doses (12 grams or more) are consistently consumed. Even after discontinuing the meds, the risk lingers for some time[1].

Cumulative doses also seem to have a significant impact on the risk of meningiomas, with higher doses (especially 60 grams or more) increasing the risk even more[1]. This information underscores the need for minding the mind-altering tumors, especially with high doses or long-term prescriptions.

1. The French court has ordered Bayer, a prominent pharmaceutical group, to pay €300,000 for its role in a patient's development of brain tumors after taking Androcur for over two decades.
2. The court found Bayer accountable for not disclosing the potential link between Androcur and the resulting brain tumors, a decision that could set a precedent for similar claims in the future.
3. This case highlights the importance of scientific research in creating health-and-wellness therapies and treatments, particularly when dealing with medical-conditions like brain tumors.

Read also: